TNFRSF4 and neuroblastoma: Owing to the significant inverse correlation shown between MYCN and TNFRSF4 in multiple neuroblastoma datasets (Figs 4–6 and S7 and S8 Figs), we next aimed to examine whether TNFRSF4 could be a bonafide MYCN target.